Literature DB >> 12901802

Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence.

Tatsuya Yoshimasu1, Yozo Kokawa, Shoji Oura, Issei Hirai, Rie Sasaki, Hirokazu Tanino, Teruhisa Sakurai, Yoshitaka Okamura.   

Abstract

UNLABELLED: We investigated whether the early postoperative time course of carcinoembryonic antigen (CEA) level after resection of lung cancer could be used to predict patients' prognosis. Fifty-three lung cancer patients were included in this study. Postoperative serum CEA levels were calculated by means of non-linear least-squares fitting to the equation C(t) = (C(0)-C(p))exp(-kt) + C(p), where C(t) is postoperative CEA level, t is days after surgery, C(0) is CEA level at postoperative time 0, C(p) is CEA level at plateau, and k is the rate constant of elimination. Postoperative CEA production (P(p)) was calculated as C(p) multiplied by k. C(p) and P(p) represent the numbers of residual tumor cells after surgery. More residual tumor cells yield higher values of C(p) and P(p), and result in earlier recurrence.
RESULTS: Kinetic parameters could be obtained for 30 patients whose preoperative CEA levels were sufficiently elevated. Cutoff levels as predictors for recurrence were 1.1 ng/ml for C(p) and 0.9 ng/ml/day for P(p). The accuracy of prediction of recurrence using these cutoff levels was 79% with C(p) and 89% with P(p). A very poor prognosis was observed for patients with P(p) over 0.9 ng/ml/day.
CONCLUSION: Analysis of the time course of changes in CEA levels after resection of lung cancer appears to be useful for predicting patient prognosis. C(p) and P(p) are very precise predictors of recurrence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901802     DOI: 10.1111/j.1349-7006.2003.tb01512.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  3 in total

1.  Annual periodic increases in serum carcinoembryonic antigen concurrent with ground-glass opacity in the lung: report of a case.

Authors:  Tsutomu Sakuma; Yumiko Iwata; Yoshimichi Ueda; Xiu Gu; Makoto Sugita; Motoyasu Sagawa
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Large-cell neuroendocrine carcinoma without immunohistological positivity or serum elevation of CEA until relapse.

Authors:  Yasutaka Watanabe; Shunsuke Endo; Hiroyoshi Tsubochi; Mitsuhiro Nokubi; Shinichiro Koyama; Yasunori Sohara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-11-12

3.  Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.

Authors:  Yoshiki Kozu; Tomohiro Maniwa; Shoji Takahashi; Mitsuhiro Isaka; Yasuhisa Ohde; Takashi Nakajima
Journal:  J Cardiothorac Surg       Date:  2013-04-22       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.